Divitren in postmenopausal climacteric disorders treatment

封面


如何引用文章

全文:

详细

In the article the data of clinical examination on Divitren application for climacteric syndrome treatment in postmenopausal women are given. The drug has shown a few side-effects, there are revealed a significant Cuperman index, gonadotropin levels decrease and estradiol level increase. The received data is evident for proper ground of Divitren application in flush disturbances treatment in postmenopausal women.

作者简介

S. Nikanorova

Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

编辑信件的主要联系方式.
Email: info@eco-vector.com
俄罗斯联邦, St. Petersburg

参考

补充文件

附件文件
动作
1. JATS XML
2. Fig. 1. FSH content in postmenopausal women before treatment and when taking Divitren (p<0.05).

下载 (1MB)
3. Fig. 2. LH content in postmenopausal women before treatment and when taking Divitren (p<0.05).

下载 (1MB)
4. Fig. 3. Estradiol content in postmenopausal women before treatment and when taking Divitren (p<0.05).

下载 (1MB)
5. Fig. 4. Prolactin content in postmenopausal women before treatment and when taking Divitren.

下载 (1MB)
6. Fig. 5. Cooperman's index.

下载 (1MB)

版权所有 © Eсо-Vector, 2000



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).